The Mayo Clinic Lipid Panel (LPSC1) screening is a comprehensive blood test that assesses an individual's lipid profile, providing crucial information about their cardiovascular health. Lipids are fatty substances found in the bloodstream, and abnormalities in lipid levels can increase the risk of heart disease and stroke. This panel typically includes measurements of total cholesterol, low-density lipoprotein (LDL) cholesterol (commonly known as "bad" cholesterol), high-density lipoprotein (HDL) cholesterol (often referred to as "good" cholesterol), and triglycerides.
By analyzing the results of the Lipid Panel (LPSC1) screening, healthcare providers can evaluate an individual's lipid levels and assess their cardiovascular risk. Abnormal lipid levels, particularly high LDL cholesterol or low HDL cholesterol, may indicate the need for lifestyle modifications, dietary changes, or medication to manage the risk of cardiovascular disease. The Mayo Clinic Lipid Panel (LPSC1) screening is a valuable tool in assessing lipid abnormalities, guiding preventive measures, and promoting cardiovascular health. Early detection and appropriate management of lipid levels are essential for reducing the risk of cardiovascular events and improving overall patient outcomes.
Click here to view sample Lipid Panel Report:
Lipid Panel (LPSC1)